The Justice Department’s Civil Division and the Department of Health and Human Services announced a six-month pilot on October 22, 2026, for healthcare companies seeking to disclose potential violations of the federal False Claims Act. The program requires companies to describe the relevant conduct, provide supporting documents, explain corrective steps and make a financial repayment. The repayment will use a multiplier of 1.25 to 1.6, with the rate determined by factors including disclosure timing, the duration and scope of the conduct, and senior-leadership involvement. In return, participants may receive a coordinated civil release under the federal FCA and certain HHS administrative authorities. Submissions must be received by April 22, 2027. Late or incomplete submissions will not be reviewed.

Why it matters

  • The pilot sets out a defined repayment framework for companies that disclose potential civil FCA violations.
  • Companies considering participation must meet the submission deadline and provide the required details and documentation.